Insights powering innovation and value creation

Hand-picked Thought Leadership pieces in the Content Hub

INTA 2026 Essentials: Where to stay, what to see and what to do
03 June 2025
Discover the INTA 2026 Essentials! This comprehensive guide will help you navigate your stay, showcasing the best accommodations, must-see attractions, and exciting activities to enjoy during your visit.
National offices report increases in national patent applications throughout Europe: Is the EPO no longer “killing” the national offices?
27 March 2026
National patent offices across Europe have reported a marked increase in patent filings in 2025, breaking with a long‑standing downward trend. Data from Germany, France, Italy, Sweden, Austria, Spain and Norway point to growing activity driven by digital technologies, electrification and increased university participation. At the same time, offices report a rise in self‑drafted and AI‑assisted applications, which may lower barriers to entry but also raise concerns about application quality and examination efficiency.
Make your bio(pharma) IP investment ready
22 March 2026
This recap of our LinkedIn Live series focuses on helping (bio)pharma businesses make their IP investment‑ready. Across three sessions, experts will discuss building resilient IP portfolios, making strategic IP decisions ahead of funding rounds, and what the evolving 2026 (bio)pharma landscape means for long‑term IP strategy.
Are professional guidelines making Patent Attorneys too cautious on AI?
19 February 2026
As AI use accelerates in patent practice, many European patent attorneys remain cautious due to professional AI guidelines from the epi. This article argues those guidelines are not a barrier, but a baseline for responsible use.
Beyond CRISPR: Precision to Platform
23 January 2026
Gene editing is entering a new phase, moving beyond CRISPR-Cas9’s breakthrough but costly, bespoke therapies toward more precise and scalable platforms. While CRISPR-based treatments like Casgevy have proven clinical success, they remain expensive and entangled in ongoing patent disputes over foundational IP. Next-generation tools such as base editing and prime editing avoid double-strand DNA breaks, enabling more accurate corrections and broader therapeutic potential. The field’s focus is now shifting to disease-agnostic platforms that can be adapted across many conditions, improving access and efficiency.
Confidentiality at the UPC: What litigants need to know
21 January 2026
This article explains how the Unified Patent Court approaches confidentiality in litigation, outlining the procedures for restricting access to sensitive information, how confidentiality clubs are formed, and when hearings may be held in private. It highlights key case law shaping these rules, the balance between fair trial rights and protection of commercial data, and the penalties for breaches. Practical guidance is provided to help parties navigate applications, manage confidential documents, and understand what to expect throughout UPC proceedings.
EPO fees are going up in April 2026: Plan ahead now
19 January 2026
The European Patent Office will introduce a fee increase of roughly 5% from 1 April 2026, affecting search, examination, designation and renewal fees. Filing, excess page, opposition and appeal fees remain unchanged. Some costs—such as renewal fees—can be paid up to three months early, allowing applicants to secure the current lower rates. EIP recommends reviewing your portfolio ahead of the deadline.
The contentious role of intellectual property in cryptographic standardisation
12 January 2026
This article explores how intellectual property rights affect the development and adoption of post-quantum cryptography standards. It highlights NIST’s proactive approach to patent licensing for new algorithms, reviews historical cases like RSA and ECC, and discusses the importance of clear IP terms for widespread cryptographic adoption.
System architecture in quantum computing – history repeating itself?
24 December 2025
This article explores the evolution of system architecture in quantum computing, drawing parallels with the early days of classical computing. It discusses the current challenges in quantum hardware, the emergence of quantum instruction set architectures (ISAs), and the potential for a RISC vs. CISC debate similar to that in classical computing. The piece highlights opportunities for innovation and intellectual property, suggesting that the choices made now could shape the future landscape of quantum technologies and licensing.
The people, physics and patents of the 2025 Nobel prize
09 December 2025
The 2025 Nobel Prize in Physics recognised John Clarke, Michel H. Devoret, and John M. Martinis for proving macroscopic quantum tunnelling in electric circuits, a breakthrough that enabled quantum computing. Their pioneering research led to hundreds of patents, including innovations in MRI and quantum technology, highlighting the real-world impact of their discoveries.
Vision 2035: The need for Innovation to meet ambitious targets set by the UK’s new critical minerals strategy
03 December 2025
The UK’s Critical Minerals Strategy 2025 sets ambitious targets to secure essential minerals for key industries by boosting domestic production, recycling, and innovation. The article highlights the vital role of intellectual property (IP) in supporting technological advances, encouraging collaboration, and strengthening the UK’s supply chains for a sustainable future.
Research underlying Nobel prize in chemistry has sparked innovation and patent filings
02 December 2025
The 2025 Nobel Prize in Chemistry recognised the creators of metal-organic frameworks (MOFs), innovative materials with huge potential for water harvesting, clean energy, and environmental solutions. Their work has sparked a surge in global patent activity and new industrial application.
UKIPO fee increases from April 2026: What it means for your IP strategy
25 November 2025
Provisional and interim injunctions both refer to temporary court orders granted before a full trial, aimed at preserving the status quo or preventing harm. In UK law, “interim injunction” is the standard term, while “provisional injunction” is less common and typically used in international contexts. Both serve the same purpose: urgent relief until the case is fully heard.
What should you look to protect in a (bio)pharma IP strategy?
18 November 2025
Sustainable models: content licensing for generative AI training
21 November 2025
It is fair to say that no technology in recent times has created so much excitement and controversy as generative AI, and in particular Large Language Models (LLMs). Generative AI companies and their backers have their sights on generating billions, if not trillions of dollars, directly or indirectly from their models. Models which, in the vast majority of cases, are trained on original works without permission from, or payment to, their authors. The works used for training are primarily obtained by scraping the open web, a uniquely vast repository of publicly accessible knowledge and information, constantly updated to reflect the latest developments in human knowledge and culture.
Emerging Practice Points from the UPC
02 September 2025
We have been keeping a close eye on the decisions coming out of the UPC and as the court starts to establish itself a number of practice points are starting to emerge.
The UPC two years on: Withdrawals of actions becoming prominent
09 June 2025
The Unified Patent Court has now been running for two years. To mark the occasion, we have looked at the cases and the decisions over the past two years, and share our thoughts on the current state...
Real Conversations, Real Innovation
EIP Talks Logo

The Latest Episodes of EIP Talks in the Content Hub

In this episode of EIP Talks, Mark Lubbock and Ellen Keenan O'Malley, solicitors at EIP, explore the full lifecycle of intellectual property, from the initial spark of innovation to the commercialisation of ideas. They share practical insights into how we support clients through the challenges of protecting, developing and monetising IP.The conversation covers how clients typically engage with us, the importance of identifying and securing various forms of IP, and the legal strategies needed to navigate collaborations, ownership, and licensing. It also highlights the significance of well-drafted contracts, website compliance and investor readiness. Whether you're launching a new product, entering a partnership, or preparing for investment, this episode offers valuable guidance on building a strong IP foundation and turning innovation into commercial success.

Hosted by Joshua Rozenberg, we bring you the inside story from the team behind the landmark Optis v Apple judgment—now the highest-value court-determined SEP license on record.Hear directly from Gary Moss, Chairman at EIP, Andy Sharples, Head of Litigation at EIP, and Arty Rajendra, Head of IP Disputes at Osborne Clarke, as they walk us through the issues which the case presented, the challenges, and the significance of the Court of Appeal’s decision to increase Apple’s license fee from $63.7 to over $700 million.We explore what this means for FRAND litigation, the future of SEP enforcement in the UK and how this ruling could impact global licensing dynamics.

Visser AI:ローンチパーティー
Visser AIのローンチパーティーにぜひご参加ください。私たちの新しいハイブリッド インテリジェンス サービスの開始を祝して、ドリンクを片手に語らいのひとときを楽しみましょう。当日は、特別ゲストのDerk Visserをはじめ、EIPのメンバーや海外拠点の同僚が集い、皆様との交流を深めながら、ローンチを祝う特別な一夜を共に過ごします。なお、当日は会場に動画撮影スタッフが入り、イベントの様子を撮影させていただきます。あらかじめご了承ください。
Celebrating 3 Years of EIP Sweden
We're delighted to invite you to celebrate three years of EIP in Sweden — a journey of growth, collaboration, and bold ideas. To mark this milestone and the opening of our new Stockholm office, we're...
Codiphy Presents: Never Mind the Broligarchs - how the UK can emerge victorious in AI
The tech bros are selling their vision of a future with AI. But should the UK buy it, or is there another way? Join us for an evening of food, drinks, and lively discussion with industry experts.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.